A British court rejected Kellogg's arguments in its legal action against the UK government over new regulations preventing it from prominently displaying some of its breakfast cereals in supermarkets due to their sugar content.
Kellogg argued that the UK government's way of measuring the nutritional value of cereal without milk or yogurt is “wrong”.
The new regulations, which come into effect in October, are designed to help tackle childhood obesity and will restrict the promotion of food and drink products that are high in fat, salt, or sugar.
Kellogg noted that it supported the government’s work to tackle obesity, demonstrated by its past efforts to reduce sugar and salt in its cereals.
A Kellogg spokesperson said that while they respect the court's decision and do not intend to appeal, they still believe that cereals should be measured with milk as it is the way most people eat them.
They also raised their concern that the government introduced these regulations without proper parliamentary scrutiny.


South Korea Ex-President Yoon Suk Yeol Sentenced to 30 Years Over Martial Law Plot
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand
Kennedy Center Ordered to Remove Trump Name Following Federal Court Ruling
Bayer Rules Out Monsanto Spin-Off as Roundup Lawsuits Continue to Mount
Trump Questions USMCA Renewal as Trade Talks Continue
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million
Sable Offshore Wins Key Court Battle Over California Oil Pipeline
Canada, British Columbia Launch $5 Billion Infrastructure Partnership to Boost Housing, Transit, and Healthcare
DOJ Investigates Group Linked to Reid Hoffman Over E. Jean Carroll Lawsuit Funding
Trump Says Anthropic No Longer Seen as National Security Threat
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Asian Stocks Surge as Oil Prices Fall and Strong US Dollar Weighs on Markets
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Australia Eases Capital Gains Tax Reforms to Support Small Businesses and Startups
Biden Sues DOJ to Block Release of Audio From Classified Documents Probe 



